Perspective Therapeutics
CATX
26 hedge funds and large institutions have $2.36M invested in Perspective Therapeutics in 2017 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 3 closing their positions.
84% more capital inflows, than outflows
Capital inflows: $607K | Capital outflows: $330K
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
0.88% less ownership
Funds ownership: 8.14% → 7.26% (-0.88%)
13% less funds holding
Funds holding: 30 → 26 (-4)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$559K |
| 2 |
Two Sigma Securities
New York
|
+$18.9K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$11.7K |
| 4 |
Bank of New York Mellon
New York
|
+$9.06K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$6.94K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Anson Funds Management
Dallas,
Texas
|
-$235K |
| 2 |
Virtu KCG Holdings
New York
|
-$53K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$26.6K |
| 4 |
Pointe Capital Management
Grosse Pointe Farms,
Michigan
|
-$12.3K |
| 5 |
Financial Architects (New Jersey)
Marlton,
New Jersey
|
-$2.93K |
CATX Hedge Fund Activity: Q1 2017 in Review
26 of the 4,035 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q1 2017, worth a combined $2.36M — down 9.3% from $2.6M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of CATX and 2 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 4 added.
The largest buyer was BlackRock, opening a new position worth an estimated $559K. The largest seller was Anson Funds Management, exiting entirely with an estimated $235K sold.
- 26 institutional investors held Perspective Therapeutics (CATX) as of Q1 2017, down from 30 in Q4 2016.
- Funds reported $2.36M of Perspective Therapeutics stock for Q1 2017, down 9.3% quarter-over-quarter.
- 2 funds opened new Perspective Therapeutics positions in Q1 2017 and 3 closed out, a net change of -1 holder.
- The largest Perspective Therapeutics buyer in Q1 2017 was BlackRock, an estimated $559K added.
- The largest Perspective Therapeutics seller in Q1 2017 was Anson Funds Management, an estimated $235K sold.
Based on aggregated 13F filings for Q1 2017.